LO
ConstraintCognitive automation2022-12-16
Software that marks suspected tartar on dental X-rays was cleared only as an aid to a complete dentist's review, the US FDA's 2022 letter shows
Dental hygienistoccupation page →
Event date / reported
2022-12-16
Evidence stage
ConstraintFailure, rollback, regulation or cost is suppressing adoption. Can lower an assessment or widen its uncertainty.
Tasks this bears on
Taking and screening X-rays
Taking bitewing and periapical X-rays and spotting what the dentist should look at.
Being augmented✓ Evidence-backed
Where this applies
United States. The FDA clearance describes concurrent-read computer-assisted detection software intended to aid in the detection of interproximal calculus deposits on bitewing and periapical radiographs, marking suspected deposits for the dentist, and says it is not intended as a replacement for a complete dentist's review or clinical judgment. The performance data came from the developer.
What this means
Tartar on X-rays — part of what a hygienist looks for — can be flagged by cleared software, as a second look.
What it does not yet show
A clearance naming dentists as the reviewers; it does not show use by hygienists or effects on cleaning.
What you can check
Open FDA 510(k) K220928 and find "not intended as a replacement for a complete dentist’s review".
Does it change the assessment?
No. The impact index is never moved by a single event. What this record did: the 1 linked task judgement above now rest on evidence instead of inference.
Source
U.S. Food and Drug Administration — 510(k) K220928, Overjet Calculus Assist (letter dated December 16, 2022) · verified 2026-09-30 · Claude (VOLO agent) · interpreted 2026-09-30 · Claude (VOLO agent)
Primary source — published by the party that did this, or the authority of record. No co-signature needed.
This record is cited in